Our Mentors

Fellows present research with their mentor at the Annual College of Gastroenterology Conference

Inspired by the enthusiasm and creativity of young scientists, DDRF mentors are acclaimed physician-scientists who commit their time and expertise to lead their DDRF Fellow through the conception, design and execution of a clinical research project. Our mentors commit time, expertise, and resources to mentoring DDRF students throughout the research year.

Download Application

Current Mentors

  • Michael Dolinger, MD, MBA is an assistant professor of pediatrics and associate pediatric gastroenterology fellowship director at the Icahn School of Medicine at Mount Sinai. Michael became the first gastroenterologist to be trained and certified to perform intestinal ultrasound in the United States by the International Bowel Ultrasound Group and he currently directs the Henry and Elaine Kaufman Intestinal Ultrasound Program at the Icahn School of Medicine at Mount Sinai, the first program of its kind in the country created to improve disease activity monitoring in IBD patients. Michael is focused on training and educating gastroenterologists in the USA and around the world to perform intestinal ultrasound, leading the development of eLearning training to meet the growing global demand and as a co-founder of iUSCAN, the intestinal ultrasound group of the United States and Canada to adapt training to the needs of North America.

  • Dr. Kushner is an Assistant Professor of Medicine in the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai with a joint appointment in the Department of Obstetrics, Gynecology, and Reproductive Sciences. She received her undergraduate degree from Cornell University, and her medical degree from Mount Sinai where she also completed her residency in Internal Medicine. She received fellowship training in Gastroenterology at the University of Pennsylvania, where she also obtained a Masters degree in Clinical Epidemiology (MSCE). She then completed a fellowship in Transplant Hepatology at the University of California San Francisco. Dr. Kushner' research focuses on liver diseases in pregnancy, with a particular interest in the impact of nonalcoholic fatty liver disease (NAFLD) on pregnancy outcomes. She has improved management of viral hepatitis during pregnancy and how we understand the impact of pregnancy on chronic liver disease. Her work has been published in numerous journals and she is a recipient of grants from the American Association for the Study of Liver Diseases (AASLD) and NIH, as well as multiple research awards.

  • Dr. Itzkowitz, MD is Professor of Medicine (Gastroenterology) and Oncological Sciences at the Icahn School of Medicine at Mount Sinai. In addition to a clinical practice, Dr. Itzkowitz is Director of the GI Fellowship Program and Co-Chair of the GI Tumor Board at Sinai. He is Co-Chair of the New York City C5 Coalition (Citywide Colon Cancer Control Coalition). Dr. Itzkowitz conducts both basic science and clinical research focused on gastrointestinal oncology. His research has focused on detecting and preventing colon cancer in inflammatory bowel disease, reducing disparities in colon cancer screening and developing new non-invasive stool DNA test for colon cancer. Dr. Itzkowitz is widely published and frequently presents at national and international medical conferences.

  • Dr. Mehandru is a physician-scientist who straddles clinical care and laboratory-based investigation. Dr. Mehandru completed his residency training in Internal Medicine at the NYU where he also served as Chief Resident, and received fellowship training in Gastroenterology at The Icahn School of Medicine at Mount Sinai. Dr. Mehandru undertook post-doctoral training at the Rockefeller University, first working in the Laboratory of Dr. David Ho (with Dr. Martin Markowitz) and then in the Laboratory of Dr. Ralph Steinman, Nobel Laureate in Physiology or Medicine, 2011. After finishing his post-doctoral training, Dr. Mehandru was invited to join the faculty at Mount Sinai where in addition to serving as an Associate Professor of Gastroenterology, he leads a laboratory of Mucosal Immunology since 2013. His laboratory studies the mucosal immune system and the host-microbial interface. He is an NIH-funded investigator who has received multiple awards.

  • Stephanie L. Gold, MD is an Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai and a gastroenterologist at the Mount Sinai Hospital, with a focus on inflammatory bowel disease (IBD) and nutrition. Dr. Gold’s clinical interests include nutrition optimization for patients with inflammatory bowel disease and the use of diet as an adjunct therapy for patients with Crohn’s disease and ulcerative colitis. She has established a unique Nutrition-IBD clinic at The Susan and Leonard Feinstein Inflammatory Bowel Disease Center, where patients have access to an in-depth nutrition and muscle health assessment as well as dietary guidance and support to complement their IBD care. Her research interests include improving the identification of malnutrition, micronutrient deficiencies and sarcopenia in patients with IBD as well as identification of dietary patterns associated with disease activity.

Past Mentors

  • Dr. Abrams is an Associate Professor of Medicine and Epidemiology in the Division of Digestive and Liver Diseases at Columbia University Medical Center. Dr. Abrams performs clinical, epidemiological, and translational research focused on Barrett's esophagus and esophageal adenocarcinoma prevention. In particular, he is interested in understanding the role of the oral and esophageal microbiome in relation to the development of Barrett's esophagus and esophageal cancer. He is also interested in non-endoscopic techniques to screen for patients at risk for esophageal cancer. Dr. Abrams previously received a K award from the National Cancer Institute, and currently serves as a Project Leader for the Barrett's Esophagus Translational Research Network (BETRNet), a NCI-sponsored multi-center research consortium.

  • Dr. Desai began his academic work with DDRF as a Fellow in 2006 when he was a medical student at Tufts University School of Medicine. After medical school graduation he completed his residency in internal medicine and his fellowship training in gastroenterology at NYU Langone Medical Center. Dr. Desai remains on the faculty of NYU, as well as working in private practice. He is widely published as either lead or co-author of more than ten clinical research studies published in peer reviewed journals. Dr. Desai’s research interests range widely including gastrointestinal endoscopy, the impact of frequently utilized medications on the digestive system and new endoscopic techniques for patients which improve the diagnosis of common digestive ailments.

  • Dr. Marron is the Director of the Early Phase Trials Unit (EPTU) at the Tisch Cancer Institute, and an Associate Professor of Medicine and an Associate Professor of Immunology and Immunotherapy at Icahn School of Medicine at Mount Sinai. Within the EPTU, he has established The Neoadjuvant Research Group to Evaluate Therapeutics (TARGET), which is a large multidisciplinary team of clinicians and scientists tasked with defining how novel therapies work through biospecimen-rich window-of-opportunity trials. This program uses immune monitoring platforms to characterize tissue, blood, and stool from patients, enabling us to define the immunodynamic changes induced by standard and novel therapies. The aim of TARGET is to more rationally design cancer immunotherapy trials, with the ultimate goal of improving patient outcomes.

  • Dr. Morton is an Associate Professor of Surgery at Stanford University serving as Section Chief of Minimally Invasive Surgery and Director of both Bariatric Surgery and Surgical Quality. He also heads the Minimally Invasive Surgery fellowship and the Stanford Center for Outcomes Research and Evaluation (SCORE) and is Co-Director of the Stanford Digestive Health Center. His research has focused on quality improvement and bariatric surgery and has published 3 books and over 100 influential articles. His clinical skills have resulted in being named Castle Connolly’s “Physician of the Year for Clinical Excellence” in 2012. He also served on Capitol Hill as Senator Bill Frist’s Health Policy Intern.

  • Dr. Ungaro is an Assistant Professor of Medicine in the Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai. Dr. Ungaro received his medical degree, residency training, and gastroenterology fellowship training from Mount Sinai where he also served as chief resident and chief gastroenterology fellow. Dr. Ungaro received training in translational inflammatory bowel disease (IBD) research as a Howard Hughes Medical Institute Research Fellow and completed a Masters in Biostatistics and Clinical Research Methods at Columbia University Mailman School of Public Health. He is Director of the Comprehensive Care for the Recently Diagnosed IBD Patient (COMPASS-IBD) Program, which provides interdisciplinary care for recently diagnosed inflammatory bowel disease (IBD) patients. His research focuses on understanding early IBD optimizing therapy via precision medicine. His work is supported by an NIH K23 Career Development Award and a Crohn's and Colitis Foundation Career Development Award.

  • Dr. Aisenberg is a Clinical Professor of Medicine at Icahn School of Medicine at Mount Sinai, New York. He graduated from Harvard Medical School, trained in internal medicine at The Columbia-Presbyterian Medical Center, and completed his gastroenterology fellowship at The Mount Sinai Hospital. His research focuses on gastrointestinal endoscopy, and also on the impact of common medications on digestive health. He has published over one hundred articles, chapters, and abstracts in leading peer-reviewed journals, and speaks nationally and internationally on gastrointestinal health and disease prevention. He is the President of the Digestive Disease Research Foundation. As featured in New York Magazine, from 2003 through the present he has been selected annually by his peers as a “Top Doctor” in New York in the field of gastroenterology.

  • Ari Grinspan, MD is an Assistant Professor in the Department of Medicine, Division of Gastroenterology and the Director of GI Microbial Therapeutics. He received his medical degree from the Albert Einstein College of Medicine in New York and completed his Internal Medicine training at New York-Presbyterian Hospital. He completed his fellowship in Gastroenterology at Mount Sinai Medical Center, where he remains as full-time faculty. Dr. Grinspan pioneered the Fecal Microbiota Transplant (FMT) program to treat recurrent and refractory Clostridium difficile infection at Mount Sinai, which has developed into a referral center for FMT. His research focuses on exploring the mechanism and clinical utility of FMT in Clostridium difficile infection and Inflammatory Bowel Disease.

  • Dr. Kim completed her undergraduate and medical degrees at Harvard College and Stanford University School of Medicine. After completing her medical training at New York–Presbyterian Hospital (Cornell), Dr. Kim joined the faculty at Mount Sinai School of Medicine. Since then, Dr. Kim’s clinical and research interests have dovetailed in gastrointestinal cancers, with specific expertise in carcinoid and neuroendocrine tumors. Dr. Kim is known nationally and internationally for her work in translational and epidemiologic approaches in assessing outcomes in patients with these tumors. Dr. Kim has received multiple research grants including the NIH KL2 Award and a Mentored Career Development Award from the American Cancer Society. Dr. Kim has also won numerous teaching awards and mentored dozens of trainees who have become junior faculty at other academic institutions. Dr. Kim is currently serving as Councilor in the American Gastroenterology Association and has served as Past President of the New York Society for Gastrointestinal Endoscopy.

  • Dr. Lightdale is a Clinical Professor of Medicine at Columbia University College of Physicians & Surgeons. Dr. Lightdale has published widely focusing on ground breaking research in Barrett’s Esophagus (BE), a condition of abnormal cell growth in the lining of the esophagus due to repeated exposure to stomach acid. Barrett’s Esophagus can lead to esophageal cancer. The early detection of these abnormal cells, can improve the treatment and prevention of this cancer. He has authored and edited more than 400 publications, including original articles, books, and monographs. In 1999, he received the Rudolf Schindler Award, the highest honor of the American Society for Gastrointestinal Endoscopy.

  • Dr. Nguyen is Professor of Medicine, Division of Gastroenterology and Hepatology, at Stanford University Medical Center. She received her medical degree from the University of California, San Diego School of Medicine and her master’s degree in clinical research at UCSF. Dr. Nguyen’s primary research interests include the molecular epidemiology and pathogenesis of hepatocellular carcinoma with an emphasis on disease determinants, diagnostic and screening tests, and ethnic differences, and the epidemiological and clinical behaviors of viral hepatitis, particularly in hepatitis C patients with novel genotypes and in under-studied populations.

  • Dr. Bamji is a Clinical Instructor of Medicine at Icahn School of Medicine at Mount Sinai. After completing his undergraduate degree in biology at Johns Hopkins University and his medical degree at Weill Medical College at Cornell University, Dr. Bamji completed an internship and residency in internal medicine and a fellowship in gastroenterology and hepatology at New York Presbyterian Hospital - Cornell Campus. Dr. Bamji has received multiple honors and has been extensively involved in research, presenting the results of his studies at both national and international conferences and venues. He has also been widely published in peer-reviewed journals and maintains active memberships in the American Society of Gastrointestinal Endoscopy and the American College of Gastroenterology.

  • Dr. Chin Hur is both a physician and a research scientist. He is a recognized expert in cancer screening and prevention for gastrointestinal cancers and is a leader within a National Cancer Institute consortium of reseachers that work towards improving cancer management. Dr. Hur has seen thousands of patients for both clinic visits and endoscopy for cancer screening and disease monitoring. He is fully committed to providing the best care possible to each patient he sees as well as improving cancer screening and prevention through his research. His clinical and research interests keep him fully abreast of the latest technologies and improvements to patient management thereby letting him provide the most up to date care for his patients.

  • Dr. Kornbluth received his medical degree from Downstate Medical University in New York, completed his residency in internal medicine as both resident and Chief Resident at the Albert Einstein College of Medicine in the Bronx, and completed his Gastroenterology fellowship at Mount Sinai. Dr. Kornbluth has trained medical students, residents, and fellows in gastroenterology and mentored visiting physicians throughout the world. He has been awarded the Solomon Berson Award at Mount Sinai for “Outstanding Physician, Teacher and Role Model”. Dr. Kornbluth has published more than 100 articles, abstracts, book chapters and invited editorials and is the Principal Author of the first three editions of the "Ulcerative Colitis Practice Guidelines in Adults,” published by the American College of Gastroenterology. He has also twice been the principal author on the chapter on Crohn’s Disease in the Sleisenger and Fordtran Textbook of Gastroenterology, the premier textbook of gastroenterology and has served as an Associate Editor for the Inflammatory Bowel Disease Journal. Currently, he is an investigator on a number of clinical trials examining new therapeutic agents in inflammatory bowel disease.

  • Dr. Lucas is an Associate Professor of Medicine in the Henry D. Janowitz Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai. She earned her undergraduate degree from Brown University with Honors and her medical degree from Yale University School of Medicine where she also completed a Howard Hughes Medical Institute Research Fellowship. She trained in Internal Medicine at New York-Presbyterian Hospital/Columbia University, serving as Chief Medical Resident. Remaining at Columbia, she pursued fellowship training in Gastroenterology and obtained a Masters Degree in Patient-Oriented Research and Biostatistics from the Mailman School of Public Health at Columbia University. Dr. Lucas’ research focuses on developing screening regimens for early pancreatic cancer detection in high-risk patients. Her work, published in gastroenterology and oncology journals, has garnered research grants from the National Institutes of Health, the American Cancer Society, and other organizations.

  • Dr. Miller is a Clinical Instructor of Medicine at The Mount Sinai School of Medicine, New York. He graduated with the highest honors from New York University School of Medicine, trained in internal medicine at Harvard University's Beth Israel Hospital, and completed his gastroenterology fellowship at The Mount Sinai Hospital in New York. His research interests include colorectal cancer screening and the development of new technologies for therapeutic applications of endoscopy. Dr. Miller has numerous publications and has presented his research at gastroenterology meetings both in the United States and abroad.

  • Dr. Triadafilopoulos is a Clinical Professor of Medicine at Stanford University School of Medicine in California. An internationally acclaimed clinician-scientist, he has authored more than 160 original research articles and 90 review papers in leading journals in the field of gastroenterology. Recently, he served as Editor-in-Chief of Gastrointestinal Endoscopy, the leading global journal devoted to the field of endoscopy. In addition, he co-directs the Gastroenterology Fellowship Training program at Stanford University. Dr. Triadafilopoulos’s research focuses on gastro-esophageal reflux disease, pre-cancerous changes in the esophagus and colon (such as Barrett’s Esophagus and polyps), and gastrointestinal motility disorders.